Paul E. Freiman Nova Bay Pharmaceuticals, Inc. (NBY) insider trading activity

NBY Quotes by TradingView

Paul E. Freiman is Director of NovaBay Pharmaceuticals, Inc.. Currently has a direct ownership of 1,716 shares of NBY, which is worth approximately $1,012. The most recent transaction as insider was on May 11, 2023, when has been sold 858 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.72K
0% 3M change
0% 12M change
Total Value Held $1,012

Paul E. Freiman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2023
BUY
Exercise of conversion of derivative security
-
858 Added 33.33%
1,716 Common Stock
May 21 2022
BUY
Exercise of conversion of derivative security
-
30,000 Added 50.0%
30,000 Common Stock
PEF

Paul E. Freiman

Director
Emeryville, CA

Track Institutional and Insider Activities on NBY

Follow NovaBay Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBY shares.

Notify only if

Insider Trading

Get notified when an Nova Bay Pharmaceuticals, Inc. insider buys or sells NBY shares.

Notify only if

News

Receive news related to NovaBay Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBY